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Alveolar rhabdomyosarcoma is an aggressive childhood muscle cancer for which outcomes are poor when the 
disease is advanced. Although well-developed mouse models exist for embryonal and pleomorphic 
rhabdomyosarcomas, neither a spontaneous nor a transgenic mouse model of alveolar rhabdomyosarcoma has 
yet been reported. We report the first mouse model of alveolar rhabdomyosarcoma using a conditional 
Pax3:Fkhr knock-in allele whose activation in late embryogenesis and postnatally is targeted to terminally 
differentiating My/6-expressing skeletal muscle. In these mice, alveolar rhabdomyosarcomas occur but at low 
frequency, and Fkhr haploinsufficiency does not appear to accelerate tumorigenesis. However, Pax3:Fkhr 
homozygosity with accompanying Ink4a/ARF or Trp53 pathway disruption, by means of conditional Trp53 or 
Ink4a/ARF loss of function, substantially increases the frequencies of tumor formation. These results of 
successful tumor generation postnatally from a target pool of differentiating myofibers are in sharp contrast to 
the birth defects and lack of tumors for mice with prenatal and postnatal satellite cell triggering of Pax3:Fkhr. 
Furthermore, these murine alveolar rhabdomyosarcomas have an immunohistochemical profile similar to 
human alveolar rhabdomyosarcoma, suggesting that this conditional mouse model will be relevant to study of 
the disease and will be useful for preclinical therapeutic testing.
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R h ab d o m y o sa rco m as a rc  a  su b s ta n tia l  p ro b le m  in  p e d i­
a tr ic  onco logy . T h e  m o s t d iff icu lt p a tie n ts  to  tr e a t  a rc  
th o s e  w ith  u n rc sc c ta b lc  lo ca l d isease  o r m c ta s ta sc s  
(W cxlcr an d  H c lm a n  1997; A rn d t an d  C ris t 1999). R h ab ­
d o m y o sa rco m a s a rc  d iv ided  in to  tw o  m ajo r h is to lo g ica l 
su b ty p es , a lv eo la r a n d  em b ry o n a l (A rnd t an d  C ris t 1999). 
A lv eo la r h is to lo g y  is  a n  in d e p e n d e n t p re d ic to r  of w o rs ­
ened  o u tc o m c , an d  c h ild re n  w ith  m e ta s ta tic  a lv eo la r 
rh ab d o m y o sa rco m as  h av e  a five-year su rv iv a l ra te  <30%  
(W cxlcr an d  H c lm a n  1997; A rn d t a n d  C ris t 1999). T h e  
u n iq u e  h is to lo g ic a l ap p ca ran cc  a n d  s ig n ific an tly  w o rse
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p ro g n o s is  fo r a lv eo la r rh ab d o m y o sa rco m as  co m p ared  
w ith  em b ry o n a l rh ab d o m y o sa rco m a  suggest th a t  a lv e o ­
la r  rh ab d o m y o sa rco m a  is  b io lo g ica lly  d is t in c t fro m  non - 
a lv co la r su b ty p es  (e.g., em bryona l). F u rth e rm o re , d esp ite  
co llab o ra tiv e  n a tio n a l tr ia ls  of m u ltim o d a l th e ra p y  an d  
a tte m p ts  a t  c h e m o th e ra p y  in te n s if ic a tio n , th e  o u tc o m c  
for p a tie n ts  w ith  ad v an ced  s tage  a lv eo la r rh a b d o m y o sa r­
co m as h a s  n o t im p ro v ed  in  m o re  th a n  tw o  dccadcs (W cx­
lc r an d  H c lm a n  1997; A rn d t an d  C ris t 1999). T h is  p la ­
te a u  in  c o n v e n tio n a l t r e a tm e n ts  su g g ests  th a t  n o v e l m o- 
lc cu la rly  ta rg e ted  th e ra p y  m ay  b e  n cccssa ry  to  t r e a t  th is  
tu m o r  cffcctivcly .
T h e  cc ll (or cclls) of o rig in  fo r a lv eo la r rh a b d o m y o sa r­
co m as is  u n k n o w n . T h e  genes an d  p ro te in s  exp ressed  by  
tu m o rs  a rc  c h a ra c te r is tic  of b o th  im m a tu re  an d  w cll- 
d iffc rcn tia tcd  cm b ry o n ic  a n d  p o s tc m b ry o n ic  m u s c lc  lin -
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cagcs (T o n in  c t al. 1991). A lth o u g h  c o n g e n ita l eases of 
a lv eo la r rh ab d o m y o sa rco m as h av e  b een  rep o rted  
(G ru n d y  c t al. 2001), 84%  of p e d ia tr ic  rh ab d o m y o sa rco ­
m a s  a rise  a f te r  th e  f irs t y ear of life  (G u rn ey  c t al. 1999), 
su g g es tin g  c ith e r  a  lo n g  la te n c y  of a n  cm b ry o n ic a lly  de­
rived  tu m o r  p re c u rso r  or, m o re  lik e ly , a  p o s tc m b ry o n ic  
o rig in  of th e  tu m o rs . In  th e  acco m p an y in g  p ap e r (K eller 
c t al. 2004), w c  sh o w  th a t  in i t ia t io n  of a lv eo la r rh ab d o ­
m y o sa rco m a  fro m  so m ite -d e riv ed  m y o g en ic  p recu rso rs , 
th e  em b ry o n ic  s a te ll i te  c e ll poo l, an d  th e  p o s tn a ta l  s a t ­
e ll ite  c e ll p o o l docs n o t o ccu r in  a m o u se  m odel. T h e re ­
fore, o u r e x p e rim e n ta l design  fo r th is  s tu d y  w as  in f lu ­
en ced  s tro n g ly  b y  th e  o b se rv a tio n  th a t  th e  im m u n o h is -  
to c h c m ic a l p ro file  of rh a b d o m y o sa rco m as is  s im ila r  to  
d iffe ren tia ted , m u ltin u c lc a tc d  sk e le ta l m u sc le , an d  th a t  
th e  s ig n a tu re  ce ll of rh ab d o m y o sa rco m a  is  th e  m u l t i ­
n u c lc a tc d  rh a b d o m y o b la s t (Q u a lm an  c t al. 1998).
M o s t a lv eo la r rh a b d o m y o sa rco m as sh a re  a c o m m o n  
g en e tic  fea tu re , th e  tra n s lo c a tio n -m c d ia tc d  fu s io n  of a 
P ax  g ene  to  a F khr  gene  (Barr c t al. 1993). T h e  t(2 ; 13)- 
m e d ia te d  P ax3:F khr  fu s io n  gene  is b e liev ed  to  p la y  a key  
ro le  in  5 5 % -7 5 %  of a lv eo la r rh ab d o m y o sa rco m as, 
w h e re a s  th e  t( l;1 3 )-m c d ia tc d  P ax7:F khr  fu s io n  gene  is 
b e liev ed  to  p lay  a k e y  ro le  in  1 0 % -2 2 %  of a lv eo la r rh a b ­
d o m y o sa rco m a s (S orensen  c t al. 2002). B o th  of th e s e  c h i­
m e r ic  genes re s u lts  in  p ro d u c tio n  of a n o v e l tra n sc r ip ­
t io n  fac to r th a t  h a s  th e  D N A -b in d in g  d o m a in  fro m  Pax3  
or P ax7 , im p o r ta n t reg u la to rs  of m u sc le  d ev e lo p m en t, 
fu sed  to  th e  p o te n t t r a n sa c t iv a tio n  d o m a in  of th e  F khr  
tu m o r  su p p re sso r (A rndt an d  C ris t 1999). T h e se  ch im e ric  
P ax:F khr  g enes a rc  b e liev ed  to  re s u lt in  a m o le c u la r  ga in  
of fu n c tio n  th a t  m ay  in  p a r t lead  to  th e  in i t ia t io n  of an  
in ap p ro p ria te  m u sc le  d e v e lo p m e n t p ro g ram  in  th e  af­
fec ted  cells.
O u r  P ax3:F khr  c o n d itio n a l k n o c k -in  a lle le  b u ild s  on  
b u t is d is tin g u ish e d  fro m  p rev io u s  in fo rm a tiv e  g e rm -lin e  
P ax3:F khr  m o d e ls  th a t  do n o t g en e ra te  tu m o rs , b ecau se  
o u r m o d e l m o re  ca re fu lly  re c a p itu la te s  th e  tra n s lo c a ­
tio n -m c d ia tc d  g en o m ic  D N A  rea rra n g e m e n t fo u n d  in  
h u m a n  tu m o rs . S pecifically , o u r  m o d e l exch an g es p o te n ­
tia lly  im p o r ta n t g en e  reg u la to ry  e le m e n ts  in  th e  3 ' ge­
n o m ic  reg io n  of Pax3  fo r th o s e  fro m  th e  3 ' g en o m ic  
D N A  of F khr. A  C rc /L o x P -m cd ia tcd  tr a n s lo c a tio n  across 
h e te ro lo g o u s  c h ro m o so m e s  w o u ld  re p re se n t th e  idea l 
m e th o d  fo r m o d e lin g  th is  cancer, an d  th is  ap p ro ach  h as 
b een  su c c e ss fu lly  d e m o n s tra te d  fo r a le u k e m ia  m o d e l 
(F orster c t al. 2003). H o w ev er, b ecau se  th e  Pax3:F khr  
fu s io n  gene  is n o t a  ro b u s t onco g en e  in  p rev io u s  germ - 
lin e  P ax3:F khr  m ic e  (A nderson  c t al. 2001; L ag u tin a  ct 
al. 2002; R claix  c t al. 2003), o th e r  a d d itio n a l g en e tic  
e v en ts  a rc  lik e ly  req u ired  fo r a lv eo la r rh ab d o m y o sa r­
c o m a  tu m o r  p rog ressio n . T h e  m u c h  g rea te r e ffic ien cy  of 
th e  k n o c k -in  ap p ro ach  v e rsu s  th e  ch ro m o so m a l tr a n s lo ­
c a tio n  ap p ro ach  (50%  vs. 10~6) p e rm its  g en e ra tio n  of th e  
fu s io n  gene  in  a  su ffic ien t n u m b e r  of ce lls  to  a llo w  for 
sp o n ta n e o u s  o ccu rren ce  of seco n d ary  g en e tic  ev en ts  a t  a 
re a so n ab le  frequency . O u r  m o d e l ad d resses th e s e  is su es.
C o n d itio n a l m o d e lin g  of a lv eo la r rh ab d o m y o sa rco m a  
in  th e  m o u se  is e sp ec ia lly  a tt ra c t iv e  b ecau se  of th e  
s tro n g  a sso c ia tio n  b e tw e e n  P ax3:F khr  an d  th is  so m a tic
tu m o r. W c h av e  g en era ted  a C rc /L o x P -m cd ia tcd  c o n d i­
t io n a l P ax3:F khr  k n o c k -in  a lle le  th a t  can  b e  tr iggered  in  
d is tin c t m y o g en ic  lineages b y  b reed in g  to  m u sc lc -sp c - 
c ific  C re  drivers. In  c o m b in a tio n  w i th  a  c o n d itio n a l F khr  
k n o c k o u t a lle le  g en e ra ted  fo r th e s e  s tu d ie s , th e  C re  
d riv er a c ts  to  re c a p itu la te  th e  t(2 ;13) h u m a n  tr a n s lo c a ­
t io n  b y  b o th  a c tiv a tin g  P ax3:F khr  an d  in a c tiv a tin g  sin g le  
n o rm a l a lle le s  of P ax3  a n d  F khr. O th e r  p u ta t iv e  in i t i a t ­
in g  ev en ts  can  a lso  b e  tr iggered  in  a m u sc lc -lin cag c-sp c- 
c ific  m a n n e r  b y  b reed in g  th e s e  a lle le s  w ith  m o u se  lin es  
h a rb o r in g  c o n d itio n a l tu m o r  su p p resso rs  o r oncogenes.
D is ru p tio n  of Ink4a/A R F  an d  T rp53  p a th w a y s  h as 
b een  im p lic a te d  as a  co o p e ra tiv e  effect fo r a lv eo la r rhab- 
d o m y o sa rco m a g cn csis  in  h u m a n s  (Felix c t al. 1992; T a- 
k a h a sh i c t al. 2004) an d  fo r n o n -a lv co la r rh ab d o m y o sa r- 
co m ag cn csis  for h u m a n s  w ith  g e rm -lin e  T rp53  m u ta ­
tio n s  (L i-F raum cni S yndrom e) o r sp o rad ic  tu m o rs  (Li an d  
F ra u m c n i 1969) as w e ll as for tra n sg e n ic  m o u se  m o d e ls  
of em b ry o n a l an d  p le o m o rp h ic  rh ab d o m y o sa rco m a  
(Jacks c t al. 1994; Sharp  c t al. 2002; F lc isc h m a n n  c t al. 
2003; N a n n i c t al. 2003). W h ile  T rp53  c o n tr ib u te s  to  
m a n y  c e llu la r  fu n c tio n s  su c h  as d if fe re n tia tio n , angio- 
gcncsis, c e llu la r  sen escen ce , a n d  ap o p to s is  (K irkw ood
2002), i ts  ov e rlap p in g  ro le  w ith  th e  Ink4a /A R F  lo cu s  
c o n tro ll in g  ce ll cycle  w ith d ra w a l v ia  th e  G l- S  c h e c k ­
p o in t is  e sp ec ia lly  re le v a n t w h e n  c o n sid e rin g  th e  p o te n ­
tia l  ce ll of o rig in  fo r rh ab d o m y o sa rco m as. Loss of re p li­
c a tiv e  c h e c k p o in t w o u ld  b e  ad v an ta g eo u s  n o t o n ly  to  th e  
ex p an sio n  of a  m y o g en ic  p re c u rso r  tra n s fo rm in g  in to  
rh ab d o m y o sa rco m a , b u t  i t  w o u ld  b e  esp ec ia lly  c r i tic a l to  
rh ab d o m y o sa rco m ag cn csis  fro m  te rm in a lly  d if fe re n tia t­
in g  m y o fib c rs  in  q u iescence .
In  th is  s tu d y  w c  rep o rt th e  f irs t m o u se  m o d e l of a lv eo ­
la r  rh ab d o m y o sa rco m a , w h ic h  h a s  b e e n  g en e ra ted  by  
c o n d itio n a l a c tiv a tio n  of P ax3:F khr  a n d  c o n d itio n a l in ­
a c tiv a tio n  of th e  In k 4 a /A rf a n d  T rp53  p a th w a y s  in  a  ta r ­
get p o o l of te rm in a lly  d iffe ren tia tin g , M y /6 -cxp rcssing  
sk e le ta l m u sc le . T h e se  tu m o rs  c lo se ly  re c a p itu la te  th e  
h is to lo g ic a l fe a tu re s  an d  im m u n o h is to c h c m ic a l p ro file  
of h u m a n  a lv eo la r rh ab d o m y o sa rco m as. T h is  rep o rt p ro ­
v ides a n  im p o r ta n t s ta r t in g  p o in t fo r u n d e rs ta n d in g  th e  
in i t ia t io n  an d  p ro g ressio n  of th is  tu m o r  an d  i ts  p o te n t ia l  
ccll(s) of o rig in .
Results
D esig n  a n d  g en era tio n  o f  ta rg e ted  m o u s e  lin e s
T h e  c o n d itio n a l P ax3:F khr  (P3Fm ) k n o c k -in  a lle le  w as 
designed  to  a llo w  n o rm a l P ax3  ex p ress io n  of th a t  a lle le  
u n t i l  C re  is p re s e n t (Fig. 1A). W ith  ex p ress io n  of C re, th is  
n o rm a lly  fu n c tio n in g  P ax3  a lle le  is  c o n v e rted  to  a 
P ax3:F khr  (P3Fa) a lle le , fu s in g  exons 1 -7  of P ax3  to  a 
9 .3 -kb  3 ' g en o m ic  reg io n  of th e  F kh r  lo cu s  c o n ta in in g  
F kh r  ex o n  2, ex o n  3, a n d  6.5 kb  of th e  u n tra n s la te d  re ­
g ion  an d  g en o m ic  D N A . S im u lta n e o u s ly , th e  eY fp  f lu o ­
re sc e n t m a rk e r  gene  is a c tiv a te d  as a  seco n d  c is tro n  
d o w n s tre a m  fro m  a n  c n c c p h a lo m y o c a rd itis  v irus-dc- 
r ived  in te rn a l rib o so m e  e n try  s i te  (IRES). T h is  design  
m im ic s  th e  d isease -asso c ia ted  tr a n s lo c a tio n  w ith  re sp ec t
M u r in e  a lv e o la r  rh a b d o m y o sa rc o m a
G E N E S &  D E V E L O P M E N T  2615
Downloaded from www.genesdev.org on July 7, 2006
K e lle r  e t  a l .
Figure L S tru c tu re  of targeted  alleles. (A )
For the  Pax3:Fkhr~targeted knock-in  allele, 
a targeting  vecto r w as designed for th e  in ­
sertio n  of a com plex cassette  in to  the  3 '-  
region of the  PaxS  gene, thereby  m odifying 
th e  la s t th ree  of 10 exons. FRT sites flank 
th e  n eo m yc in  resistance  gene (Neo) and a l­
low  excision of th is  gene upon  breeding to 
an Flp-e m o u se  (Rodriguez e t al. 2000). T h e  
P3Fp allele ind ica tes the  p resence of th e  
n eo m yc in  resistance  gene (Neo+j, w hereas 
th e  P3Fm  allele ind ica ted  th e  absence of th e  
n eo m yc in  resistance  gene (Neo- ). LoxP 
sites flank  exons 8-10  of PaxS  as w ell as an 
in serted  p o ly adeny lation /stop  signal from  
th e  C o m p lem en t2  (C2) gene. P rio r to  ac ti­
vation , th e  P3Fm  allele w ill transcribe  a 
fu ll-leng th  PaxS  transcrip t. U pon  ac tiv a ­
tio n  by CRE, exons 8-10  and  the  stop signal 
are rem oved  and exon 7 of PaxS  is ju x ta ­
posed to  exons 2  and  3 of Fkhr/ thereby cre­
a tin g  an activ ated  Pax3:Fkhr fusion  allele 
[PSFa). A n  in te rn a l ribosom al en try  s ite  
(IRES) d ow nstream  from  F khr  exon 3 allow s 
for b ic istron ic  expression of eYFP. T he  p o ­
sitio n s of PCR genotyp ing  p rim ers ck82, 
ck83, and  cklO  are show n. (TK1) T h y m i­
dine k inase; (FRT) Flp-e recom binase  recog­
n itio n  sequence; (RI) EcoRI re stric tio n  site?
(RV) EcoRV re s tr ic tio n  site; (UTR) u n tra n s ­
la ted  region. (B) For the  F khr conditional 
m ouse  line, a targeting  vecto r w as designed 
for w h ich  exons 2  and 3 w ere flanked  by 
Lox511 sites. T h e  F2-3p a llele  ind ica tes th e  
p resence of th e  n eo m yc in  resistance  gene 
(Neo+), w hereas the  F2-3m  allele ind ica tes 
th e  absence of the  n eo m yc in  resistance  
gene (Neo- ). In  th e  presence of CRE, th e  in ­
activated  DEL2-3 allele is generated. T h e  
p o sitio n s of PCR genotyping p rim ers 
c k l4 2 , c k l4 3 , and  ck30 are show n. (C) For 
th e  M yf6~G re  a llele, a targeting  vecto r w as 
designed for the  in se rtio n  of a com plex cas­
se tte  in to  th e  3 '-region of the  M yf6  gene. A t
an engineered  X hol site  in  the  3 ?-UTR, an IRES-C re w as in serted  to  a llow  b ic istron ic  expression of M yf6  and  Cre. A n  FR T -N eo-FR T  
cassette  w as in serted  3 ' to  IRES-Cre. T he  IC N p allele  ind ica tes th e  presence of the  n eo m yc in  resistance  gene (Neo+), w hereas th e  
IC N m  allele ind ica tes its  absence. T h e  p o sitio n s of PCR genotyping p rim ers ck219, ba88, and  ba86 are show n.
to  P ax3:F khr  ex p ress io n  b e in g  d ire c te d  by  th e  P ax3  p ro ­
m o te r , a n d  b e in g  p o te n t ia l ly  in f lu e n c e d  by  3 ' F kh r  cis- 
reg u la to ry  e le m e n ts  k n o c k e d  in to  th e  P ax3  lo cu s . G erm - 
lin e  m ic e  w e re  e s ta b lish e d  ca rry in g  th e  c o n d itio n a l N eo -  
c o n ta in in g  P ax3:F khr  a lle le  {Pax3P3Fp/wT) (data  n o t  
show n). A fte r re m o v in g  th e  p o s itiv e  se le c tio n  c a sse tte  
by  F lpe-m ed ia ted  reco m b in a tio n , ISfeo-excised P ax3F3Fm/wt 
an d  p ax 3 P3Fxn/P3Fxn m ic e  p ro v e  to  b e  v iab le  a n d  fe rtile , 
b reed in g  n o rm a lly . W h ereas m ice  a n d  h u m a n s  h e te ro z y ­
gous fo r P ax3  lo ss-o f-fu n c tio n  m u ta tio n s  a re  re ad ily  dis- 
ce rn ab le  b ecau se  of th e i r  d e fic ien c ie s  of m e la n o c y te  p ro ­
d u c tio n  (G ou ld ing  e t  a l. 1993; T assab eh ji e t  a l. 1993), 
P a x3 P3Fm/wt m ic e  w i th o u t  C re  re se m b le  w ild - ty p e  m ice  
an d  h a v e  n o rm a l c o a t c o lo r p ig m e n ta tio n . I t  th e re fo re  
ap p ears  th a t , in  th e  ab sen ce  of C re , th e  ta rg e te d  m o d ifi­
c a tio n s  in tro d u c e d  in to  th e  P ax3  lo c u s  do n o t  a ffec t n o r ­
m a l Pax3 fu n c tio n .
T h e  F kh r  c o n d itio n a l k n o c k o u t a lle le  w as  desig n ed  to  
a llo w  n o rm a l ex p ress io n  of th a t  a lle le  u n t i l  C re  is  p re ­
s e n t (Fig. IB). U p o n  C re  ex p ressio n , th is  fu n c tio n a lly  
n o rm a l F kh r  a lle le  is  in a c t iv a te d  by  ex c is io n  of ex o n s  2  
an d  3 re m o v in g  th e  D N A -b in d in g  d o m a in  a n d  th e  fu ll 
tran sac tiv a tio n  dom ain  of th e  F k h i  gene. G erm -lin e  m ice  
w ere  estab lished  an d  con firm ed  by S ou thern  analysis to  
carry th e  co n d itio n a l N eo -co n ta in in g  a lle le  [FkhxF2'3p/WT) 
(data  n o t  show n). T h e  N e o -e x c is ed  F kh rF2‘3ni/WT an d  
F k h rF2'3ni/F2‘3ni m ic e  a re  v iab le  a n d  fe rtile , b reed in g  
n o rm a lly . H o m o zy g o u s  FM irOEL2~3/UEL2"3 m ice  w ith  
g e rm -lin e  ab sen ce  of b o th  F kh r  a lle le s  d ie  by  em b ry o n ic  
day 10 (E10) (data  n o t  show n), c o n s is te n t w ith  p rev io u s
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re p o r ts  fo r n o n c o n d itio n a l F kh r  a lle le s  (H osaka e t  al. 
2004).
T o  a llo w  C re  ex p ressio n  in  a  ta rg e t p o o l of d iffe ren ti­
a tin g  sk e le ta l m u s c le  fo llo w in g  th e  en d o g en o u s  ex p res­
s io n  p a tte rn  of M y/6  (Fig. 1C), w e  desig n ed  a n  M y f6 -C re  
a lle le . T h is  a lle le  exp resses C re  as  a  seco n d  c is tro n  from  
an  IRES d o w n s tre a m  fro m  th e  M y/6  gene . G e rm -lin e  
m ic e  ca rry in g  th is  a lle le  w e re  e s ta b lish e d  (data n o t 
show n). U n lik e  p re v io u s ly  rep o r te d  m ic e  w ith  3 ' M y/6  
m o d if ic a tio n s  th a t  a lte r  th e  n o rm a l ex p ress io n  of M y/6  
a n d /o r  ad ja c e n t M y/5  g en e  (O lson  e t  a l. 1996), o u r 
M y f 6 IC M n i/W T  an d  M y/6 iCMm//CMm m ic e  a re  v iab le  and  
fe r tile  as b o th  h e te ro z y g o te s  an d  h o m o zy g o te s , b reed in g  
n o rm a lly . By sm a ll a n im a l c o m p u te d  to m o g rap h y , th e se  
a n im a ls  a lso  la ck e d  th e  rib  a b n o rm a litie s  (data  n o t 
show n) p rev io u sly  seen  in  M yf6 /M yf5  lo ss-o f-fu n c tio n  
a lle le s  (Braun an d  A rn o ld  1995).
T o  te s t  th e  m u sc le -sp ec if ic  p a tte rn  of ex p ress io n  of o u r 
M y f6 -C re  a lle les , w e  cro ssed  m ic e  ca rry in g  th e  M y /6 -  
C re  a lle le  to  m ic e  ca rry in g  th e  R osa26  L acZ  rep o rte r  
(Sorriano 1999). In  th e  la t te r  m o u se , p ro d u c tio n  of L acZ  
m R N A  is b lo ck ed  by  a  s tro n g  p o ly a d e n y la tio n  sig n a l 
f la n k e d  by  LoxP s ite s . In  th e  p re se n c e  of C re , th e  b lo c k ­
in g  c a s s e tte  is exc ised  an d  L acZ  m R N A  a n d  p -galac to si- 
dase  p ro te in  a re  sy n th e s iz e d . S how n  in  F igure 2A  is 
w h o le -m o u n t p -g a lac to s id ase  s ta in in g  of a n  E l 5.5 e m ­
bryo  h e te ro zy g o u s  fo r b o th  a lle le s  (M y/6iCMm/vl/T 
G tro sa 2 6 trnlSor/WT). E m bryos of th is  g en o ty p e  e x h ib it a 
sk e le ta l-m u sc le -sp ec ific  p a tte rn  of C re  ex p ressio n . T o  
co n firm  th a t  th e  M y f6 -C re  a lle le  w as  exp ressed  in  th e  
ta rg e t poo l of te rm in a lly  d if fe re n tia tin g  m yofibers , and  
n o t  in  s a te ll i te  ce lls, w e  lo o k ed  for co ex p ress io n  of 
n u c le a r  p ro te in s  C re  an d  Pax7 in  ]/[yf6ICMrn/WT m ic e  by 
im m u n o h is to c h e m is try  in  c ro ss-sec tio n  of sk e le ta l 
m u s c le  of 3 -w eek -o ld  m ice . N o n -o v erlap  of th e s e  m a rk ­
e rs  in  F igure 2B d e m o n s tra te s  th a t  C re  is n o t  p re s e n t in  
P ax7 -exp ressing  s a te ll i te  cells; h o w ev er, im m u n o h is to ­
c h e m is try  fo r C re  an d  m y o g en ic  tr a n sc r ip tio n  fac to r 
M yoD  in  F igure 2C  d e m o n s tra te s  co ex p ressio n  of th e se  
m a rk e rs  in  th e  sa m e  n u c le i as h a s  b een  p re v io u s ly  
sh o w n  fo r p o s tn a ta l te rm in a lly  d if fe re n tia tin g  m y o fib ers  
(C o rn e liso n  an d  W old  1997).
C o n d itio n a l p r o d u c tio n  o f  th e  P ax3:F khr fu s io n  
p ro te in  in  s k e le ta l  m u s c le
T o  g e n e ra te  th e  P ax3 :F kh r p ro te in  in  sk e le ta l m u sc le , w e  
c ro ssed  m ic e  ca rry in g  th e  P ax3:F khr  k n o c k -in  a lle le  to  
m ic e  ca rry in g  th e  M y f6 -C re  a lle le . P a x3 PBFa/WT 
M y f6 ICMni/WT o ffsp ring  w e re  v iab le , fe rtile , a n d  p re s e n t 
in  M en d e lia n  ra tio s . T o  v isu a liz e  th e  e x te n t of C re-in - 
du ced  fo rm a tio n  of th e  P ax3:F khr  fu s io n  g en e  in  sk e le ta l 
m u sc le , w e  h a rv e s te d  th e  v a s tu s  la te ra lis  m u s c le  from  
th e s e  m ic e  as w e ll as fro m  c o n tro l m ic e  a n d  ex am in ed  
th e  ex p ressio n  of th e  P ax3:F khr  rep o rte r, eYFP. E pifluo- 
re scen ce  m ic ro sco p y  of th e se  m u s c le s  in  c ro ss-sec tio n  
sh o w ed  eYFP ex p ress io n  in  -5 0 %  of th e  ce lls, su g g estin g  
th a t  th e  C re -m ed ia ted  re a rra n g e m e n t of th e  P ax3:F khr  
lo c u s  w as  in c o m p le te  am o n g  m a tu re  m u s c le  fibers  (Fig.
M u rin e  a lv e o la r  rh a b d o m y o sa rc o m a
Figure 2. C harac te riza tio n  of th e  PaxSrFkhr, M yf6-C re  experi­
m en ta l system . [A] T h e  M yf6~C re  a lle le  d em o nstra tes a ske l­
e ta l-m uscle-specific  p a tte rn  of expression  in  an  E l5.5 fe tu s car­
ry ing  th e  ROSA26 C re-activatab le  L a cZ  m arker. (B ) N uclear - 
localized C re  (green) and  th e  nu c lear sa te llite  cell m ark e r Pax? 
(red) are n o t coexpressed in  cross-sectioned sk e le ta l m u sc le  of 
M yf6~C re  m ice . (C) C re  and  th e  p o st-sa te llite  cell m yogenic 
tran scrip tio n  facto r M yoD  are coexpressed in  sk e le ta l m u sc le  of 
M yf6~C re  m ice . (D) W hen crossed to  th e  Pax3:Fkhr cond itional 
knock-in  allele, th e  M vf6~C re  a llele  causes heterogeneous ex­
p ression  of th e  eY fp  m ark e r of Pax3:Fkhr ac tiv a tio n  in  cross­
sec tioned  sk e le ta l m u sc le  of a 6-w eek-old m o u se  [right), w ith  
lit t le  au tofluo rescence  in  tissu e  of a con tro l m o u se  [left). (£) 
G enom ic  D N A  PCR of th e  Pax3:Fkhr locus from  a 6-w eek-old 
m o u se  carrying th e  M vf6~C re  a llele  confirm s heterogeneous ac­
tiv a tio n  of Pax3:Fkhr w ith in  each sk e le ta l m u sc le  sam ple  from  
varying epaxial and  hypaxial sites . A c tiv a tio n  of Pax3:Fkhr in  
te s te s  is  no ted . (F) R T-PC R  of sk e le ta l m u sc le  tis su e  from  a 
6-w eek-old m o u se  carrying b o th  th e  Pax3:Fkhr knock-in  a llele  
and  th e  M yf6~C re  a lle le  d em o nstra tes Pax3:Fkhr tran scrip t ex­
p ression  for th e  tissu es show n  to  undergo genom ic rearrange­
m e n t of th e  Pax3:Fkhr kno ck -in  allele.
2D), w h ic h  is ad v an ta g eo u s  for d e m o n s tra t in g  th a t  t u ­
m o rs  a rise  from  P ax3 :F khr-expressing  ce lls.
T o  verify  th a t  th e  P ax3:F khr  k n o c k -in  a lle le  w as  b e ing  
p a r t ia l ly  rea rran g ed  by  th e  M y f6 -C re  d riv e r a t  th e  ge­
n o m ic  lev e l in  a  sk e le ta l-m u sc le -sp ec ific  m a n n e r , w e  
p e rfo rm ed  PC R  of g en o m ic  D N A  fro m  a  v a rie ty  of t i s ­
sues from  P ax3F3Fa/WT M y f6 ICNn2/WT a n im a ls . P ax3:P khr
G E N E S  &  D E V E L O P M E N T  2617
Downloaded from www.genesdev.org on July 7, 2006
K elle r e t  a l.
re a rra n g e m e n ts  (Fig. 2E) w e re  p re s e n t n o t o n ly  in  h y p ­
ax ia l sk e le ta l m u sc le  (low er leg, lo w er arm ) b u t a lso  in  
cp ax ia l sk e le ta l m u sc le  (d iaphragm , tongue). T h e  
P ax3:F khr  a lle le  w as n o t rea rran g ed  in  card iac  m usc le , 
b u t a  tra c e  re a rra n g e m e n t w as p re se n t in  te s te s . H o w ­
ever, th e  b an d  for th e  u n rca rran g cd  P ax3:F khr  k n o c k -in  
a lle le  w as s t i l l  p re s e n t in  e ach  sk e le ta l m u s c le  tis su e  
te s ted , suggesting , as sh o w n  b y  eY fp  m ic ro sco p y  of s k e l­
e ta l m u sc le , th a t  th e  a c tio n  of C re  o ccu rred  in  -5 0 %  of 
th e  d if fe re n tia tin g  sk e le ta l m u sc le  m yofibcrs .
T o  co n firm  th e  p re sen ce  of th e  P ax3:F khr  t r a n sc r ip t in  
sk e le ta l m u s c le  tis su e s  of 6 -w cck -o ld  P ax3p3Fu/WT 
M y f6 ICNlll/WT m ice , w c  p e rfo rm ed  n e s te d  R T -P C R  u s in g  
5 ' P ax3  ex o n  6 a n d  3 ' F khr  exon  2 p rim e rs  (Fig. 2F). 
A n a ly s is  rev ea led  th e  ex p ec ted  p a tte rn  of h y p ax ia l (upper 
a n d  lo w er lim b) an d  cp ax ia l (tongue, back , d iaph ragm , 
a n d  p cc to ra lis) sk c lc ta l-m u sc lc -sp cc ific  Pax3:F khr  ex ­
p ressio n , as w e ll as tra c e  ex p re ss io n  in  th e  te s te s . N o n ­
spec ific  ex p re ss io n  in  card iac  m u sc le  o r liv e r w as ab sen t.
M ice  exp ressin g  P ax3 :F kh r d eve lo p  
a lveo la r rh a b d o m y o sa rc o m a
M ice  ca rry in g  th e  P ax3:F khr  k n o c k -in  a lle le  a n d  a M yf6-  
spcc ific  C re  d riv e r w e re  fo llo w ed  for up  to  29 m o  (T able 
1). A  tu m o r  o ccu rred  in  o n e  of 228 a n im a ls  a t  12 m o  of 
age. T h is  tu m o r  is sh o w n  in  F igure 3A . M icro scop ic  
c o m p u te d  to m o g rap h y  (m icroC T ) of th e  a n im a l rev ea led  
th e  p re sen ce  of a p c d u n c u la tin g  tu m o r  a ris in g  fro m  th e  
p cc to ra lis  m a jo r m u sc le , w ith  s te lla te  in te rn a l ca lc ifica ­
t io n  su g g es tiv e  of n ec ro s is  (Fig. 3B). O n  n ec ro p sy  th e  
tu m o r  w as h ig h ly  v a scu la r (Fig. 3C). H is to lo g y  of th e  
tu m o r  a t  lo w  m a g n if ic a tio n  rev ea led  th e  a t ta c h m e n t  of
n o rm a l sk e le ta l m u s c le  a t  th e  tu m o r  base  (Fig. 3D). 
H ig h e r p o w er m a g n if ic a tio n  rev ea led  d en se ly  packed , 
sm a ll, ro und , b lu e  ce lls  w ith  sc a n t cy to p la sm  an d  c o rru ­
g a tin g  v esse ls  c o n s is te n t w ith  th e  so lid  v a ria n t of a lv eo ­
la r rh ab d o m y o sa rco m a  (Fig. 3E). A n  ex am p le  of th e  so lid  
v a ria n t of a lv eo la r rh ab d o m y o sa rco m a  fro m  h u m a n  is 
sh o w n  in  F igure 3F for co m p ariso n . T h e  d iag n o sis  w as 
co n firm e d  by  p o s itiv e  im m u n o h is to c h e m is try  for m yo- 
g c n in  (Fig. 3G). Im m u n o h is to c h e m is try  fo r sm o o th  
m u sc le  a c tin  a n d  m u sc le -sp ec ific  a c tin  w as  a lso  p o s itiv e  
(data n o t show n). T o  p rov ide  su p p o r tiv e  ev id en c e  th a t  
th is  tu m o r  w as no n sp o rad ic , w c  g en o ty p ed  tw o  a reas of 
th e  tu m o r, d e m o n s tra tin g  th a t  th e  c o n d itio n a l P 3F m  a l­
le le  h a d  b een  c lo n a lly  co n v e rted  to  th e  a c tiv a te d  P3Fa 
a lle le  (Fig. 3H), ra th e r  th a n  ex h ib itin g  a n o n a c tiv a tc d  
c o n d itio n a l a lle le  o r h e te ro g e n e ity  of n o n a c tiv a tc d  an d  
a c tiv a te d  a lle le s . T herefo re , th e  tu m o r  w as  d eriv ed  from  
a M y f6 -C rc -cx p rc ss in g  cell.
H a p lo in s u ff ic ie n c y  o f  F k h r d o es n o t  s ig n if ic a n tly  
a cce lera te  tu m o r ig e n e s is
T h e  rec ip ro ca l ch ro m o so m e  2 a n d  13 tra n s lo c a tio n s  o b ­
se rved  in  h u m a n  a lv eo la r rh ab d o m y o sa rco m as  re s u lt in  
fou r g en e tic  conseq u en ces : fo rm a tio n  of th e  Pax3:F khr  
fu s io n  gene, fo rm a tio n  of th e  re c ip ro ca l F khr:P ax3  fu s io n  
gene, lo ss of a  s in g le  Pax3  a lle le , an d  p e rh ap s  m o s t s ig ­
nificantly, th e  loss of a single Fkhr allele. T o  te s t th e  possi­
b ility  th a t Fkhr loss contribu tes to  th e  pathogenesis of alveo­
lar rhabdom yosarcom a, w c generated a  conditional allele of 
Fkhr mid in troduced  it in to  Pax3p3Fa/WT M yf6ICNin/WT m ice. 
W c fo llo w ed  96 P ax3p3Fa/WT p k h r F2~3jl2/WT M y f6 ICNlIl/WT 
a n im a ls  fo r u p  to  25 m o  w ith o u t  th e  d e v e lo p m e n t of a
Table 1. M ice genera ted  for th is s tu d y
G enotype (n)
Age (days) 
m edian , range




Pax3:Fkhr he terozygote  lines
M vf6JCNm/any Pux3I'3ta/w 1 — — 228 348, 35-889 1 383
M yf6lCNm/any Pax3p3Fa/WT F kh iF2~3ni/WT — 96 332, 49-739 0 NA
M yf6,CNm/any Pax31'3Fa/wl F kh iF2~3lll/WT Tip53F2~10/WT 57 282, 76-406 0 NA
M yf6,CNm/any Pax3F3Fa/WT — Tlp53F2-10/WT 16 235, 89-406 0 NA
M vf61CNmMny Pax31'3Fa/wl — Trp53F2'-! 0/F2-J 0 12 75, 65-295 0 NA
M vf6lCNm/any Pax3v3Fa/WT — Ink4a!A R F F2-3/WT 68 235, 16-393 0 NA
M vf6lCNm/any Pax3p3Fa/WT — In k4 a /A R F F2-3/F2-3 31 72, 47-295 0 NA
C ontro l lines
M yf6ICNmteny --- — Tip53F2'10/WT 50 262, 41-399 0 NA
M vf6ICNm/any --- — Trp53F'- n)>F'- n) 5 72, 57-303 0 NA
M vf6ICNm/cmy --- — In k4 a /A R F FP-3/WT 57 269, 41-388 0 NA
M vf6IGNm/cmy --- — In k4 a /A R F F'‘-3/F'‘-3 18 62, 41-295 0 NA
Pax3:Fkhr h o m o zyg o te  lines
M yf6ICNm/any p axgP3Fci/P3Fci — --- 36 21 9 ,4 4 -5 4 2 0 NA
M vf6ICNm/any Pax3P3Fa/P3Fa — Trp53F'- w lw r 12 2 1 6 ,7 8 -4 0 6 1 202
M yf6ICNni/cmy Pax3P3Fa/P3Fa — Trp53F'" 10/F'"10 5 89, 72-295 2 75-91
M yf6ICNni/any Pax3P3Fa/P3Fa — In k4 a /A R F FP-3/WT 13 195, 66-295 0 NA
M yf6,CNni/any Pax3P3Fa/P3Fa ____ In k4 a /A R F F'-3/F'-3 14 72, 47-108 4 56-89
N A  = no t applicable, 
any = IC N m  or W T  allele.
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M u rin e  a lv e o la r  rh a b d o m y o sa rc o m a
Figure 3. A lveolar rhabdom yosarcom a 
in  Pax3:Fkhr M yf6-C re  m ice. (A) A  12- 
m onth-old female Pax3P3Fa/WT M yf6ICNm/WT 
m o u se  w as found  to  have  a large m ass 
(black arrow head) arising  from  th e  left 
ches t w all n ear th e  axilla. [B] C om puted  
tom ography scan revealed  a w ell-c ircum ­
scribed 13.8 x 6.4 x 9 -m m  m ass (w hite a r­
row head) a rising  from  a m ore  in filtra tiv e  
base. A  ste lla te  area of calcification  w as 
ind ica tiv e  of cen tral necrosis w ith in  th e  
tum o r. (C) G ross d issec tion  revealed  a 
h igh ly  vascular, rubbery  tu m o r. (D) Low- 
p ow er m agn ifica tion  of th e  hem atoxy lin - 
and  eosin -sta ined  tu m o r (blue) dem on­
stra tes  ad h eren t skeletal m u sc le  (pink). [E) 
H igher-pow er m agn ifica tion  of th e  h e m a ­
toxylin- and  eosin-stained  tu m o r show s 
densely packed  cells w ith  scan t cy to ­
p lasm , co n sisten t w ith  th e  so lid  v a rian t of 
a lveo lar rhabdom yosarcom a. (F) A  h u m an  
solid  v a rian t of alveo lar rhabdom yosar­
com a is  sh o w n  for com parison. (G) Im m u ­
n o h isto ch em is try  fo r m yogen in  is  p o si­
tive . [H) G enotyp ing  of tw o  areas of th e  
tu m o r reveals clonal conversion  of th e  
cond itional P3Fm a lle le  to  an  activated  
P3Fa allele.
tu m o r  (T able  1). W e th e re fo re  co n c lu d e d  th a t  h ap lo in - 
su ffic ien cy  of F kh r  does n o t  s ig n ific an tly  a cce le ra te  tu - 
m o rig en es is  w h e n  P ax3 :F kh r is  ex p ressed  in  th e  M yf6 
d o m a in  fo r te rm in a lly  d if fe re n tia tin g  sk e le ta l m u sc le .
In k 4 a /A R F  a n d  T rp53  m u ta t io n s  
a cce lera te  tu m o r ig e n e s is
B ecause  h u m a n  a lv eo la r rh ab d o m y o sa rco m as  f re q u e n tly  
carry  m u ta tio n s  in  th e  Ink4a /A R F  and  T rp53  p a th w ay s , 
w e  w ish e d  to  te s t  w h e th e r  m u ta t io n s  th a t  p ro m in e n tly  
affec t G l - S  c e ll cycle  re -e n try  co u ld  a cce le ra te  th e  fo r­
m a tio n  of a lv eo la r rh ab d o m y o sa rco m as  fro m  a ta rg e t 
p o o l of q u ie sc e n t, te rm in a lly  d if fe re n tia tin g  M y/6 -ex ­
p re ss in g  sk e le ta l m u sc le . For th is  goal, w e  in tro d u c e d  
c o n d itio n a l k n o c k o u t a lle le s  fo r IN K 4 a /A R F  (A guirre e t  
al. 2003) o r Trp53  (Jonkers e t  al. 2001) in to  o u r  P ax3:F khr  
m o d e l. A  to ta l  of 57  c o n tro l m ice  w ith  th e  gen o ty p e  
In k 4 a /A R F p2-3/WT M y f6 ICNm/WT an d  50  m ic e  w ith  th e
gen o ty p e  Trp53p2-10/WT M y f6 lCN™/WT  w ere  fo llo w ed  fo r 
u p  to  13 m o  w ith o u t  th e  d e v e lo p m e n t of a lv eo la r rh a b ­
do m y o sa rco m as. W e a lso  fo llo w ed  68 tr ip le  h e te ro z y ­
gous P a x3 P3paMt In k 4 a /A R F p2-3/WT M y f6 ICNkB/WT m ice  
and  16 tr ip le  h e te ro zy g o u s  P a x3 P3Fa/wt T rp53P2’10/WT 
M y f6 lCNui/WT a n im a ls  fo r u p  to  13.5 m o  w ith o u t  th e  d e­
v e lo p m e n t of a tu m o r  (T able  1).
T o  increase th e  frequency of tum ors, w e began breeding for 
com pound hom ozygotes. A  to ta l of 18 Ink4a /A R F P2'3/P2‘3 
M y f6 ICN™/WT  c o n tro l m ice  an d  five  Tip 5 3 F2~10/p2~10 
M y f 6 lC N n i/W T  c o n tro l m ice  re m a in  cancer-free  fo r 10 m o . 
H ow ever, in  o u r  f i r s t  a n im a l h o m o zy g o u s fo r th e  
P ax3:F khr  k n o c k -in  a lle le  an d  h o m o zy g o u s  fo r th e  
IN K 4 a /A R F  k n o c k o u t a lle le , w e  o bserved  a so f t tis su e  
m a s s  a ris in g  fro m  th e  to n g u e  b ase  (Fig. 4A) a t  age 3 m o . 
M ic ro C T  rev ea led  a la rge  n e c k  m ass  en cas in g  th e  t r a ­
ch ea  (Fig. 4B), w h ic h  w as a lso  e v id e n t on  n ec ro p sy  (Fig. 
4C). H is to lo g y  of th is  tu m o r  rev ea led  c la ss ic  a lv eo la r 
rh ab d o m y o sa rco m a  w ith  en trap p ed  n o rm a l sk e le ta l 
m u s c le  (Fig. 4D ). Im m u n o h is to c h e m is try  rev ea led  th e
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K e lle r  e t  a l .
Figure 4. Alveolar rhabdomyosarcoma in 
Pax3:Fkhr Myf6~Cre mice w ith  cell cycle 
control m utations. Three anim als w ith 
Trp53 or Ink4a/ARF m utations tha t have 
developed classical alveolar rhabdomyo­
sarcomas. {A,F,K) Gross appearance of the 
tum ors of the tongue/jaw, chest/arm, and 
upper and lower extremities, respectively, 
marked w ith black arrowheads. (BfGfL ) Mi- 
croCT of the tumor(s) for each animal 
demarcated by w hite arrows. (CfH fM ) Ap­
pearance of the tum ors (white arrowheads) 
at necropsy. (D,I,N) Hem atoxylin and eo- 
sin staining of the tum ors dem onstrating 
classical alveolar histology and entrapped 
skeletal muscle (D, black arrowhead), 
strap cell (D, inset), and m ultinucleated 
rhabdom yoblasts [N, inset). (.EJfO ) Im m u­
nohistochem istry for myogenin was posi­
tive for each tumor.
tu m o r  to  b e  m y o g e n in  p o s itiv e , co n firm in g  th e  h is to lo g i­
ca l d iagnosis . T h re e  m o re  m ice  w ith  th e  id e n tic a l g en o ­
ty p e  h a v e  a lso  d eve loped  u n ifo c a l a lv eo la r rh a b d o m y o ­
sa rco m as of th e  m a sse te r , n e c k , o r a n te r io r  c h e s t  w a ll a t  
age 2  m o  (data  n o t  show n).
B ecause  th e  IN K 4 a /A R F  g en e  p ro d u c ts  in f lu e n c e  b o th  
T rp53  a n d  pR b  p a th w a y s , w e  so u g h t to  d e te rm in e  w h ic h  
p a th w a y  w as p rim a rily  re sp o n s ib le  fo r rh ab d o m y o sa rco - 
m ag en e sis . W e beg an  b reed in g  fo r m ic e  w ith  c o m p o u n d  
c o n d itio n a l P ax3:F khr  h o m o zy g o u s a lle le s  an d  co n d i­
tio n a l Trp53  a lle le s . In  th e se  m ice , w e  o b se rv ed  a  so ft 
t is s u e  tu m o r  a ris in g  fro m  th e  r ig h t p e c to ra lis  m a jo r 
m u s c le  of a  6 .7 -m o n th -o ld  P ox3P3Fa/P3Fa Trp53F2' 10/wt 
M y f6 ICNni/WT a n im a l (Fig. 4F -H ). H is to lo g y  of th is  tu ­
m o r  rev ea led  c la s s ic  a lv eo la r rh ab d o m y o sa rco m a  (Fig. 
41). A s w as th e  case  fo r th e  p r io r  tu m o r , n u m e ro u s  m u l­
tin u c le a te d  rh ab d o m y o b la s ts  w ere  p re se n t. Im m u n o h is ­
to c h e m is try  rev ea led  th e  tu m o r  to  b e  m y o g e n in  p o sitiv e , 
co n firm in g  th e  h is to lo g ic a l d iagnosis . In  a  seco n d  m o u se  
th a t  w as h o m o zy g o u s  in s te a d  of h e te ro zy g o u s  fo r th e  
c o n d itio n a l Trp53  a lle le , w e  o bserved  e a rlie r  o n se t (age 3 
m o) fo r fo u r  m u lti fo c a l tu m o rs  a ris in g  fro m  th re e  ex ­
tr e m itie s  (Fig. 4K -M ). T h e se  tu m o rs  a lso  e x h ib ite d  c la s ­
s ic  a lv eo la r rh a b d o m y o sa rc o m a  h is to lo g y  a n d  m y o g en in  
im m u n o p o s it iv ity  (Fig. 4 N ,0 ) .  A n  id e n tic a l p a tte rn  of 
m u lti fo c a l lim b  tu m o rs  w as o bserved  in  a  2 .5 -m o n th -o ld  
a n im a l of th e  sa m e  gen o ty p e . By im m u n o h is to c h e m is ­
try , T rp53  w as a b se n t fro m  each  of th e se  a lv eo la r rh a b ­
d o m y o sa rco m a s fro m  Ink 4 a /A R F  o r T rp53  a n im a ls . W e 
th e re fo re  su g g est th a t  T rp53  p a th w a y  d is ru p tio n , e ith e r  
fo r i t s  c e ll cy c le  c o n tro l ro le  o r o th e r  ro les , c o n tr ib u te s  to  
a lv eo la r rh ab d o m y o sa rco m a  fo rm a tio n  in  P ax3:F khr  
m ice .
T o  a n sw e r  th e  u n d e rly in g  q u e s tio n  w h e th e r  h o m o z y ­
g o sity  fo r P ax3:F khr  w as a  n ece ssa ry  a n d  su ff ic ie n t e v e n t 
fo r tu m o r  fo rm a tio n  in  th is  m o d e l, ir re sp e c tiv e  of T rp53  
o r Ink4a /A R F  m u ta tio n s , w e  o bserved  36  d o u b le  h o m o ­
zy go te  P ax3P3Fa/F3Fa M y f6 lCMni/ICMni m ic e  fo r u p  to  18 
m o  w ith o u t  th e  fo rm a tio n  of tu m o rs ; ho w ev er, a  sm a ll 
n u m b e r  of m ic e  w ith  h o m o zy g o u s  d e le tio n  of In k 4 a /  
A R F  o r  T rp53  a n d  o n ly  a  h e te ro zy g o u s  P ax3:F khr  a lle le  
h av e  n o t  developed  tu m o rs  w ith in  th e  sa m e  p e rio d  of 
t im e  as a n im a ls  w ith  h o m o zy g o u s  d e le tio n  of In k 4 a /  
A R F  o r  T rp53  a n d  h o m o zy g o u s  P ax3:F khr  a lle le s , su g ­
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M u rin e  a lv e o la r  rh a b d o m y o sa rc o m a
g estin g  for th is  m o u se  m o d e l th a t  tw o  P ax3:F khr  a lle le s  
m ay  b e  req u ire d  fo r tu m o rig en es is .
M u r in e  a lveo la r  rh a b d o m y o sa rc o m a s  h a v e  
an  im m u n o h is to c h e m ic a l  p ro file  s im ila r  to  h u m a n  
a lveo la r  rh a b d o m y o sa rc o m a s
T o  a ssess  th e  s im ila r i ty  of th is  p re c lin ic a l m o d e l of a l­
v e o la r rh ab d o m y o sa rco m a  to  th e  h u m a n  d isease , w e  ex­
a m in e d  th e  im m u n o h is to c h e m ic a l p ro file  of th e  m u r in e  
tu m o rs . A  su m m a ry  is  p re s e n te d  in  T a b le  2, a n d  rep re ­
s e n ta tiv e  s ta in in g  for P a x3 pspa/wt In k 4 a /A R F p2-3/WT 
M y f 6 IC N n i/W T  tu m o rs  is  sh o w n  in  F igure 5. T h e  h ep a to - 
c y te  g ro w th  fac to r recep to r, c -M et, is  a k n o w n  d o w n ­
s tre a m  ta rg e t of P ax3 :F kh r ex p ressed  by  a lv eo la r rh ab d o ­
m y o sa rco m a s  (G insberg  e t  al. 1998J an d  w as focally  p re ­
s e n t in  a ll m u r in e  a lv eo la r rh ab d o m y o sa rco m as  (T able  2 ; 
Fig. 5A). Pax7 ex p ressio n  w as a lso  p re s e n t in  m u r in e  a l­
v e o la r rh ab d o m y o sa rco m as  (Fig. 5B), as h a s  b een  re ­
p o r te d  fo r m a n y  h u m a n  a lv eo la r rh ab d o m y o sa rco m as, 
a lb e it a t  lo w  lev e ls  (T iffin  e t al. 2003; T o m e sc u  e t  al.
2004). In  h u m a n  a lv eo la r rh ab d o m y o sa rco m a  sam p le s  
w e  te s te d , Pax7 ex p ress io n  c o m p arab le  o r g rea te r th a n  
o u r m u r in e  tu m o rs  w as seen  in  6 of 3 2  cases (see S upp le­
m e n ta ry  Fig. SI A). S im ila rly , th e  h u m a n  rh a b d o m y o sa r­
c o m a  m a rk e r  M yoD  (T on in  e t  al. 1991) w as u n ifo rm ly  
ex p ressed  in  th e  m u r in e  tu m o rs  (Fig. 5C). T rp53  w as ex­
p re sse d  in  th e  tu m o r  w ith o u t  T rp53  o r In k 4 a /A R F  c o n ­
d it io n a l d e le tio n , b u t  a d is tin c tio n  co u ld  n o t b e  m a d e  
b e tw e e n  w ild - ty p e  a n d  m u ta te d  T rp53  (T able  2). In  th is  
tu m o r , m u r in e  p l9 A R F  w as n o t ex p ressed  (data  n o t 
show n), su g g estin g  th a t  T rp53  fu n c tio n  w as in ta c t .  N e v ­
e rth e le s s , th e  d o w n stre a m  effec to r of G l - S  ce ll cy c le  re- 
re n try , C y c lin  D l  (C avenee  2002), w as s tro n g ly  ex­
p re sse d  in  a ll m u r in e  a lv eo la r rh ab d o m y o sa rco m as  (Fig. 
5D). C -M Y C , a p ro life ra tiv e  fac to r ex p ressed  in  so m e  h u ­
m a n  a lv eo la r rh ab d o m y o sa rco m as  (K ourak lis  e t  a l. 1999) 
th a t  o ften  acco m p an ie s  an  a p o p to tic  d efec t (N ilsso n  a n d  
C lev e lan d  2003), w as s tro n g ly  ex p ressed  in  m u r in e  a l­
v e o la r rh ab d o m y o sa rco m as  for a ll g en o ty p es  (Fig. 5E) a t  
c o m p arab le  lev e ls  to  th e  h u m a n  rh ab d o m y o sa rco m as  w e 
te s te d  (see S u p p lem en ta ry  Fig. SIB); fu r th e rm o re , th e  
P ax3:F khr  ta rg e t gene  an d  a n tia p o p to tic  fa c to r Bcl-XL 
(M argue e t  al. 2000) w as u n ifo rm ly  exp ressed  acro ss  a ll 
m u r in e  rh ab d o m y o sa rco m as  (Fig. 5F). A  le ss  co m m o n  
m a rk e r  of h u m a n  a lv eo la r rh ab d o m y o sa rco m as, N e u  
(M ark e t  al. 1998), w as a b se n t from  a ll m u r in e  
P ax3:F khr-exp re ss in g  tu m o rs . C D 44 , a favo rab le  prog-
Figure 5. R epresen tative  im m u n o h is to ch em ica l profile of a l­
veolar rhabdom yosarcom as from  p a x3P3Fa/wt In k4a /A R F F2'3/WT 
M yf6ICNm/WT m ice . T u m o rs expressed m yogenic m arkers com ­
m on  to h u m an  alveolar rhabdom yosarcom as, in clud ing  c-M et 
(A), Pax7 (B), and  M yoD  (C). (D) T he  cell cycle re -en try  m arker, 
C yclin  D l ,  w as strongly  expressed. (£) O th e r m arkers com m on 
to  h u m a n  and  m ouse  alveolar rhabdom yosarcom as in clu d ed  C- 
M YC. (jP) T he  an ti-apop to tic  p ro te in , Bcl-XL, w as strongly  ex­
pressed and  appeared to  localize to  th e  nu c lear m em brane  as has 
been  previously  reported  (Hsu e t al. 1997). [Insets] H igher m ag­
n ifica tio n  of positive ly  sta in in g  cells (w hite arrow head).
n o s tic  m a rk e r  of h u m a n  rh ab d o m y o sa rco m as  th a t  is  
ty p ica lly  a b se n t from  a lv eo la r rh a b d o m y o sa rco m as 
(H u m p h rey  e t  al. 1999), w as a lso  a b se n t in  th e  m u r in e  
a lv eo la r rh ab d o m y o sa rco m as.
Discussion
T h e  a lv eo la r su b ty p e  of rh ab d o m y o sa rco m a  p o rte n d s  a 
p o o r p ro g n o s is  w h e n  th e  d isease  is  ad v an ced  (W exler and  
H e lm a n  1997). A lth o u g h  w e ll-c h a ra c te r iz e d  em b ry o n a l 
and  p le o m o rp h ic  rh ab d o m y o sa rco m as  m o u se  m o d e ls  ex ­
is t, n e ith e r  a sp o n ta n e o u s  n o r a tra n sg e n ic  m o u se  m o d e l 
of a lv eo la r rh ab d o m y o sa rco m a  h as  y e t  b een  rep o rted . In  
th is  m a n u s c r ip t  w e  re p o r t a fa ith fu l m o d e l of a lv eo la r 
rh ab d o m y o sa rco m a  b u il t  on  th e  s ig n a tu re  g en e tic  
ch an g e  of th is  tu m o r . U s in g  c o n d itio n a l m u ta g e n e s is  to  
s im u la te  e v e n ts  th a t  o ccu r as a r e s u lt  of a t(2;13) tr a n s ­
lo c a tio n  asso c ia te d  w ith  h u m a n  a lv eo la r rh a b d o m y o sa r­
com as, w e  h a v e  b een  ab le  to  c o n v e rt a fu n c tio n a lly  n o r ­
T able 2. Im m u n o h is to c h em ic a l profile  o f  m u r in e  a lveo lar rhabdom yosarcom as
G enotype c-M et Pax7 M yoD Trp53
C yclin
D l C-M YC Bcl-XL N eu CD44
M y f6 l CNm/an y Pax3P3Fa/WT — 4-4-4- 4- 4-4- 4-4- -h-h-h 4-4- 4-4- 0 0
MyffrtCNm/rmy PaX^PSFa/PSFa Trp53F2'10/WT 4-4- 4-4- 4-4- 0 4-4- 4-4- 0 0
MyffrtCNm/rmy PaX^PSFamFa Trp5 SF2'-1 °^p2-10 4-4- 4- 4-4- 0 4-4- 4-4- 0 0
MyftfCNm/any PaX^PSFamFa In k4 a iA R F F2-3/F2-3 4-4- 4-4- 4-4- 0 -h-h-h 4-4- 4-4- 0 0
Sem i q u an tita tiv e  scoring is  based  on  th e  scale u sed  by G reen e t al. (1993). In  brief, 0 equals no sta in ing , + equals w eakly  positive  
sta in ing , ++ equals strongly  positive  sta in in g  eq u iv a len t to  th e  con tro l, and  +++ equals very strongly  p ositive  sta in ing .
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m a l P ax3  a lle le  to  a P ax3:F khr  a lle le . In  th is  repo rt, 
P ax3:F khr  a c tiv a tio n  w as re s tr ic te d  to  a ta rg e t p o o l of 
te rm in a lly  d if fe re n tia tin g  M y/6 -ex p ressin g  sk e le ta l 
m u sc le . In  P ax3P3Fu/WT M y f6 ICNlll/WT m ice , a lv eo la r 
rh ab d o m y o sa rco m as  a re  ra re  (1 in  228). H ow ever, 
P ax3:F khr  h o m o zy g o s ity  an d  In k 4 a /A R F  or Trp53  p a th ­
w ay  lo ss  of fu n c tio n  s ig n ific a n tly  acce le ra te s  a lv eo la r 
rh ab d o m y o sa rco m a  fo rm a tio n  fro m  th is  ta rg e t pool, ra is ­
in g  th e  in te re s t in g  p o ss ib il ity  th a t  so m e  or m o s t a lv eo la r 
rh ab d o m y o sa rco m as  a rise  fro m  p o s tn a ta l, te rm in a lly  d if­
fe ren tia tin g , M yf6 -exp ress ing  m y ofibers . H ow ever, w e  
ca n n o t ru le  o u t th e  p o ss ib ility  th a t  w ith in  th e  p o s tn a ta l 
My f 6  c e ll p o p u la tio n  th e re  is  a y e t- to -b e -id en tif ied  su b ­
p o p u la tio n  of p r im itiv e  n o n d if fe re n tia tin g  m yogen ic  
cells, s im ila r  to  th o s e  th a t  tr a n s ie n t ly  exp ress  M yf6 in  
th e  m y o to m e  of th e  ro s tra l s o m ite  b u t th a t  do n o t n e c ­
e ssa rily  c o n tr ib u te  to  em b ry o n ic  m u s c le  m ass  (Bober e t 
al. 1991; S u m m e rb e ll e t al. 2002).
T h e se  m o u se  a lv eo la r rh ab d o m y o sa rco m as  derived  
fro m  a ta rg e t p o o l of m a tu r in g  m y o fib ers  h av e  a n  im m u - 
n o h is to c h e m ic a l p ro file  th a t  c lo se ly  p a ra lle ls  h u m a n  a l­
v eo la r rh ab d o m y o sa rco m as, in c lu d in g  a  m a rk ed ly  dis- 
reg u la ted  a rray  of ea rly  m y o g en ic  m a rk e r  ex p ressio n  
(e.g., m yo g en in , M yoD , an d  Pax7), k n o w n  P ax3 :F kh r ta r ­
ge ts  (e.g., c-M et, Bcl-XL), an d  m a rk e rs  of p ro life ra tio n  
(e.g., C -M yc an d  C y c lin  D l) .  B ecause  of th is  im m u n o - 
h is to c h e m ic a l s im ila r i ty , th e  in h e r ite d  im m u n o c o m p e - 
te n c y  of th e  c o n d itio n a l m o u se  m odel, a n d  th e  a b il ity  to  
fo rm  tu m o rs  in  s itu , th a t  is, fro m  a n o rm a l m u s c le  e n ­
v iro n m e n t, th is  m o d e l p ro m ise s  to  b e  v a lu a b le  for s tu d ­
ies of tu m o r  b io logy  as w e ll as for p re c lin ic a l th e ra p e u tic  
te s tin g .
For th e  p a rad ig m  of a c c u ra te ly  m o d e lin g  tra n s lo c a ­
tio n -m e d ia te d  tu m o r  in i tia tio n , th e re  a re  fo u r s ig n ific an t 
g en e tic  ch an g es to  ta k e  in to  a c c o u n t w ith  each  fu s ion . In  
th e  case  of th e  t(2 ; 13) tra n s lo c a tio n  in  a lv eo la r rh ab d o ­
m yo sa rco m as, tw o  fu s io n  genes a re  c rea ted : Pax3:F khr  
an d  F khr:P ax3. W h ereas P ax3:F khr  is c o n s is te n tly  t r a n ­
sc rib ed  in  tu m o rs  an d  is co m p o sed  of fu n c tio n a l e le ­
m e n ts  fro m  b o th  P ax3  an d  F kh r  (A rnd t an d  C ris t 1999), 
F khr:P ax3  is  exp ressed  in  a fra c tio n  of tu m o rs  te s te d  
(F rascella e t  al. 1998) an d  co n s is ts  of o n ly  a p a r t ia l F khr  
D N A -b in d in g  d o m a in  an d  a p a r tia l P ax3  tr a n sa c t iv a tio n  
d o m a in . T h e  tw o  less  ap p rec ia ted  g en e tic  changes a sso ­
c ia ted  w ith  t(2 ; 13) a re  th e  d e s tru c tio n  of o n e  a lle le  of 
P ax3  and  th e  d e s tru c tio n  of o n e  a lle le  of F khr. W hereas 
P ax3  h ap lo in su ff ic ien cy  is k n o w n  to  cau se  W aard en b u rg  
S y n d ro m e  in  h u m a n s  (T assabeh ji e t  al. 1993), a  co n d itio n  
n o t a sso c ia te d  w ith  rh a b d o m y o sa rco m as or tu m o rig en - 
esis, th e  effec ts of h a p lo in su ff ic ie n c y  of th e  p u ta t iv e  t u ­
m o r su p p re sso r F kh r  a re  u n k n o w n . T o  te s t  th e  h y p o th ­
esis th a t  h ap lo in su ff ic ien cy  of th e  tu m o r  su p p resso r 
F kh r  m ay , indeed , b e  a sso c ia te d  w ith  th e  in i t ia t io n  a n d / 
or p ro g ress io n  of a lv eo la r rh ab d o m y o sa rco m a , w e  in t ro ­
duced  a c o n d itio n a l k n o c k o u t a lle le  of F kh r  in to  
P ax3P3Fu/WT M y f6 ICNnl/WT m ice . For th is  m odel, F khr  
h ap lo in su ff ic ien cy  does n o t ap p ea r to  s ig n ific a n tly  a cce l­
e ra te  tu m o rig c n c s is  in  P ax3P3Fu/WT F kh rF2 3^nl/WT 
M yf6 ICNn'l/WT a n im a ls . H ow ever, w e  h av e  ex p e rim e n ts  
ongo ing  to  d e te rm in e  w h e th e r  F kh r  h ap lo in su ffic ien cy ,
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as a d o w n s tre a m  effec to r of PT E N , a c ts  sy n e rg is tic a lly  
w ith  In k4a /A R F  or T rp53  lo ss  of fu n c tio n  in  th e  acc e l­
e ra tio n  of rh ab d o m y o sa rco m ag en esis .
In  o u r m odel, tu m o rs  m o s t o ften  a rise  fro m  m ic e  h o ­
m ozygous for th e  P ax3:F khr  a lle le  (a lth o u g h  th e  a n im a l 
w ith o u t Trp53  o r In k 4 a /A R F  k n o c k o u t a lle le s  th a t  d e ­
v e loped  a  tu m o r  a t  age 12 m o  w as h e te ro zy g o u s  for 
P ax3:F khr). T h is  o b se rv a tio n  ra ises  th e  p o ss ib ility  th a t  
dosage of th e  P ax3:F khr  k n o c k -in  a lle le  is im p o r ta n t for 
tu m o r  in itia tio n , an d  th a t  in  o u r c o n s tru c tio n  of th e  
k n o c k -in  a lle le , a lb e it as ca re fu lly  as w as possib le , w e 
w ere  m iss in g  an  im p o r ta n t p o s itiv e  c is -reg u la to ry  e le ­
m e n t fro m  th e  F kh r  3 ' g en o m ic  region, or w e  d id  n o t 
e l im in a te  a n  im p o r ta n t n eg a tiv e  c is -reg u la to ry  e le m e n t 
fro m  th e  Pax3  3 ' g en o m ic  reg ion . A lte rn a tiv e ly , i t  m ay  
s im p ly  b e  a re s u lt fro m  spec ies-spec ific  lev e ls  of t r a n ­
sc r ip tio n  fro m  th e  P ax3  lo cu s . T h is  w ill  b e  a n  a rea  of 
fu r th e r  in v e s tig a tio n .
It h ad  b e e n  a n  o p en  q u e s tio n  w h e th e r  a lv eo la r rh a b ­
d o m y o sa rco m a s in i t ia te  befo re  or a f te r  b ir th , and  
w h e th e r  c e r ta in  su b se ts  of m y o g en ic  p ro g en ito rs  a re  
m o re  su sc e p tib le  to  g ive  rise  to  th is  m a lig n an cy . P e d ia t­
ric  c an ce rs  a re  fre q u e n tly  a sso c ia te d  w ith  tra n s lo c a tio n s , 
and  th e s e  tra n s lo c a tio n s  a re  o ften  a s y m p to m a tic  a t b ir th  
(G reaves and  W iem e ls  2003). In  th e  a c c o m p an y in g  
m a n u s c rip t (K eller e t al. 2004), w e  h av e  described  th e  
e m b ry o n ic  an d  p o s tn a ta l  co n seq u en ces  of P ax3:F khr  ex ­
p re ss io n  w ith in  su b s e ts  of th e  P ax3  ex p re ss io n  d o m ain . 
T h e se  re s u lts  suggest a  fram ew o rk  for th e  m o le c u la r  
ga ins of fu n c tio n  for Pax3:F khr, as w e ll as th e  p o te n t ia l  
cell(s) of o rig in  for a lv eo la r rh ab d o m y o sa rco m as. T h e  se ­
v e rity  of b ir th  defec ts in  P ax3P3Fuhvt R a jC reT g anj/"rt or 
P ax3P3Fu/'vt p a x 7ICNlll/'vt m ic e  an d  a sso c ia te d  le th a li ty  
suggest th a t  th e  tr a n s lo c a tio n  ev e n t in  h u m a n s  is  u n ­
lik e ly  to  o ccu r e ith e r  as a  g e rm -lin e  m u ta t io n  or as a 
m o sa ic  in  a  b road  ran g e  of e m b ry o n ic  m y o g en ic  p re c u r­
sors. Based on  th e i r  n o rm a l cap ac ity  for se lf-ren ew al and  
p ro life ra tio n  d u rin g  p o s tn a ta l  m y o g en es is  an d  m u sc le  re ­
pair, p o s tn a ta l  m u l tip o te n t s te m  cells  in  m u s c le  (e.g., 
s id e  p o p u la tio n  cells) an d  c o m m itte d  m u s c le  s te m  cells 
(i.e., s a te ll i te  cells) a re  th e o re tic a lly  th e  b e s t can d id a te s  
for b e in g  th e  ce lls  of o rig in  for a lv eo la r rh a b d o m y o sa r­
com as, b u t  u n t i l  n o w  th e  th e o ry  h a s  n o t b een  te s ted .
R esu lts  fro m  o u r a cco m p an y in g  p ap e r (K eller e t al.
2004) go on  to  d e m o n s tra te  th a t  P ax3P3Fu/'vt p a x 7ICNnl/'vt 
m ice  ca rry in g  th e  ac tiv a te d  P ax3:F khr  a lle le  in  th e  Pax7+ 
p re n a ta l an d  p o s tn a ta l  s a te ll i te  c e ll p o o ls  do n o t develop  
tu m o rs  even  u p  to  3 .5  m o  of age, w e ll in to  th e  y o u n g  
a d u lth o o d  of th e s e  m ice . By in fe ren ce  fro m  th is  ex p e ri­
m e n t for w h ic h  P ax3P3Fuhvt P a x 7ICMlll/"rt m ic e  h av e  a 
sev e re ly  d im in ish e d  s a te ll i te  ce ll p o o l an d  in h ib ite d  
Pax7 ta rg e t g ene  ac tiv a tio n , fo rm a tio n  of th e  h u m a n  2; 13 
ch ro m o so m a l tr a n s lo c a tio n  sh o u ld  o ccu r in  e m b ry o n ic  
or n e o n a ta l m u s c le  lin eag es on ly  a fte r  n o rm a l P a x 7 ex ­
p re ss io n  is no  lo n g er c r i tic a l for e s ta b lish m e n t o r re ­
n e w a l of th e  s a te ll i te  c e ll pool, su c h  as d u rin g  m y o b la s t 
d if fe re n tia tio n  fo llo w in g  th e  p o s tn a ta l  re sp o n se  to  
m u sc le  in ju ry — or th e  tr a n s lo c a tio n  sh o u ld  o ccu r in  o n ly  
a  sm a ll m in o r i ty  of Pax7+ s a te ll i te  cells.
O u r re s u lts  in  th is  re p o r t ra ise  th e  in te re s t in g  p o ss i­
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b il i ty  th a t  te rm in a lly  d if fe re n tia tin g  s k e le ta l m u sc le  
m y o fib e rs  h av e  th e  cap a c ity  to  g ive  rise  to  a lv eo la r rh a b ­
d o m y o sa rco m a s, w h ic h , in  tu rn , can  exp ress  m a rk e rs  
(m yogen in , M yoD , Pax7) of e a r lie r  m y o g en ic  p recu rso rs . 
T h is  re s u lt m a y  n o t b e  su rp ris in g  g iv en  th a t  fu lly  d iffer­
e n tia te d  m a tu re  sk e le ta l m u s c le  h a s  b een  d e m o n s tra te d  
to  h a v e  th e  cap ac ity  to  d e d if fe re n tia te  in to  ea r lie r  p re ­
cu rso r m y o g en ic  fo rm s o r ev en  in to  d iffe ren t lineages 
(O delberg  e t al. 2000). O n e  m ig h t ex p ec t th a t  for a te r ­
m in a lly  d iffe ren tia ted  ce ll to  b eg in  rep lica tin g , lo ss  of 
ce ll cyc le  c h e c k p o in t w o u ld  b e  n ecessa ry , c o n s is te n t 
w i th  th e  fac t th a t  a q u a rte r  of h u m a n  rh ab d o m y o sa rco ­
m a s  h av e  a b e rra n t o r a b se n t T rp53  (Felix e t  al. 1992) or 
Ink4a /A R F  (Io lascon  e t al. 1996) ex p ressio n . F u r th e r­
m o re , g row ing  ev id en c e  fro m  n o n -a lv eo la r rh ab d o m y o ­
sa rco m a  m o u se  m o d e ls  su g g ests  th a t  m u ta tio n s  a ffec t­
in g  ce ll cyc le  c o n tro l s ig n if ic a n tly  in c re a se  rh ab d o m y o ­
sa rco m a  freq u en cy  for m ic e  w i th  a b e rra n t g ro w th  fac to r 
ex p re ss io n  (see S u p p le m e n ta ry  T a b le  1). W ith  regard  to  
cell(s) of o rig in , th e  re s u ltin g  lo ss  of re p lic a tiv e  check - 
po in t(s) w o u ld  p e rh ap s  b e  ad v an ta g eo u s  to  th e  ex p an sio n  
of a m y o g en ic  p re c u rso r  tra n s fo rm in g  in to  rh a b d o m y o ­
sa rco m a , b u t  w o u ld  b e  c r i tic a l to  rh ab d o m y o sa rco m a  
a ris in g  fro m  te rm in a lly  d if fe re n tia tin g  m y o fib ers  in  q u i­
escen ce . W e th e re fo re  p o s tu la te  th a t  m a n y  b u t p e rh ap s 
n o t a ll h u m a n  P ax3 :F khr-cxprcssm g  a lv eo la r rh ab d o ­
m y o sa rco m a s a re  derived  fro m  d if fe re n tia tin g  m yofibers . 
T h e se  ce lls  w o u ld  p re su m a b ly  re q u ire  c e ll cyc le  c h e c k ­
p o in t lo ss  of fu n c tio n .
In  su m m a ry , w e  rep o rt a m o u s e  m o d e l of a lv eo la r 
rh ab d o m y o sa rco m a , w h ic h  h a s  b e e n  g en era ted  b y  co n d i­
tio n a l a c tiv a tio n  of P ax3:F khr  an d  c o n d itio n a l in a c t iv a ­
tio n  of th e  T rp53  p a th w a y  in  a ta rg e t p o o l of te rm in a lly  
d iffe ren tia tin g , M y /6 -ex p ressin g  s k e le ta l m u sc le . T h is  
rep o rt p ro v id es th e  s ta r t in g  p o in t  for u n d e rs ta n d in g  th e  
in i t ia t io n  an d  p ro g ress io n  of th is  tu m o r  an d  i ts  p o te n t ia l  
cell(s) of o rig in . F u rth e rm o re , th is  c o n d itio n a l g en e tic  
m o d e l w ill  b e  a v a lu a b le  to o l for u n d e rs ta n d in g  th e  
u n iq u e  b io lo g y  of a lv eo la r rh ab d o m y o sa rco m as  an d  w ill 
se rv e  as an  ex c itin g  n e w  p re c lin ic a l p la tfo rm  for te s tin g  
n e w  th e ra p e u tic  s tra teg ie s .
Materials and methods
G enom ic  clones iso la tion
G enom ic  D N A  clones w ere iso lated  from  a X bacteriophage li ­
brary  of m ouse stra in  SvJ-129 (Stratagene). T hese  clones con­
sisted  of a 14.2-kb clone spanning  in tro n  7 to th e  3 ' u n tran sla ted  
region of Pax3, an  18.9-kb clone spanning  in tro n  2 to  th e  3 ' 
u n tran s la ted  region of Fkkr, and  a 12-kb clone spanning  exon 8 
and th e  3 ' u n tran s la ted  region of M yf6.
Targeted m o u se  line pro d u c tio n
For th e  Pax3:Fkhr cond itional m ouse line, a targeting  vector 
w as co n stru c ted  for w h ich  LoxP sites flan k  exons 8-10  of Pax3 
a t A flll and BstXI sites, respectively . T h e  com pact polyadenyla- 
tio n  signal and transcrip tio n a l pause  e lem en ts  from  the 
C om plem ent.2  gene 3 ' u n tran s la ted  region (Ashfield e t al. 1991; 
M oreira e t al. 1995) is in serted  u p stream  of th e  native  Pax3
polyadenylation  signal and the  3 ' LoxP site. T he 3 ' LoxP site  is 
follow ed by Fkhr  genom ic D N A  co n ta in ing  338 bp of in tro n  1, 
2.9 kb con ta in ing  exon 2 /in tro n  2 /exon  3, and 6.5 kb of th e  3 ' 
un tran s la ted  region and genom ic D N A . A n  in te rn a l ribosom e 
en try  site  from  encephalom yocardial v irus and th e  enhanced  
yellow  fluo rescen t p ro te in  eYfp  w ere in serted  in  exon 3 a t a Bglll 
site. T h is targeting  vector w as e lectroporated  in to  R I em bry­
on ic  stem  cells (Nagy e t al. 1993), and th e  cells w ere subjected 
to positive  and negative selec tion  (M ansour e t al. 1988). G e­
n om ic  D N A  from  144 colonies w as analyzed by Southern  h y ­
b rid ization  using  a 3 ' ex te rnal probe to iden tify  12 clones w ith  
a targeted  m odification  of th e  Pax3 locus. S outhern  hybrid iza­
tio n  using  an  in te rn a l probe and EcoRI-digested genom ic D N A  
was used to  fu rth e r iden tify  th ree  clones th a t con ta ined  the  
desired 5 ' LoxP site  from  th e  targeting  vector. C ells  from  these 
th ree  reco m b in an t clones w ere m icro in jected  in to  C57BL/6 
b lastocysts to generate ch im eric  m ice. C h im eric  m ice were 
m ated  to C57BL/6 fem ales, and th e ir  A gouti offspring were 
tested  by S outhern  hybrid ization  to  confirm  germ -line tran s­
m ission  of th e  Pax3:Fkhr cond itional allele. T he FRT-flanked 
n eo m yc in  resistance  gene {Neo) was rem oved by breeding 
Pax31'3Fp/M m ice to transgenic  m ice expressing Flp-e (Rodriguez 
et al. 2000), thereby generating  Pax3p3l,,nhvt m ice.
For th e  F khr cond itional k n o ck o u t m ouse line , a targeting  
vector w as constru c ted  for w h ich  Lox511 sites flan k  exons 2 and 
3 of th e  Fkhr  gene. T h is targeting  vecto r w as e lectroporated  in to  
R I em bryonic  s tem  cells subjected  to positive  and negative se­
lection . G enom ic  D N A  from  71 colonies w as analyzed by 
Southern  h ybrid ization  using  a 3 ' ex ternal probe to  iden tify  41 
c lones w ith  a targeted  m odification  of th e  Fkhr locus. C h im eric  
and germ -line m ice w ere produced as discussed above.
For th e  M yf6 -C re  m ouse line, a targeting  v ecto r w as con­
stru c ted  th a t p laced an  ircs-C rc-F R T -N co -F R T  cassette  a t an  
engineered Xhol site  w ith in  th e  u n tran s la ted  region of th e  th ird  
exon of th e  M yf6  gene, 226 bp after th e  stop  codon. T h is targ e t­
ing v ecto r show n in  Figure 1C w as e lectroporated  in to  RI e m ­
bryonic  s tem  cells subjected  to  positive  and negative selection . 
Tw o of 70 clones w ere  iden tified  as positive  by screening w ith  
Aflll, N col D N A  digests and S outhern  h y brid ization  using  a 5' 
ex te rnal probe, as d em onstra ted  by a dow nshift from  11.2 to  7.3 
kb (data n o t shown). C h im eric  and germ -line m ice w ere p ro ­
duced as discussed above.
M u r in e  a lv e o la r  rh a b d o m y o sa rc o m a
G enotyp ing
M ice carry ing  targeted  a lleles w ere genotyped by PCR. For the 
Pax3:Fkhr m ouse line, th e  5 ' and 3 ' p rim ers w ere ck82, 5 '-G G A  
T T G C A T G G T T G G G A T G T A G C T G -3 '; ck83, 5 '-CAAAGAAG 
C A A C A G A G G G A G A TG -3'; and cklO  5 '-T G A G C A T C C A C  
C A A G A A C TC -3'; respectively. D N A  w as ex tracted  from  tails, 
and 2 pL (5-20 ng) w as used  in  th e  subsequen t PCR reaction . 
Each 25 pL of PCR reac tion  co n ta ined  lx  buffer, 2.5 m M  M gC l,, 
200 p M  deoxynucleotides, 0.6 pM  ck82, 0.3 pM  ck83, 0.3 pM  
cklO , and 0.75 U of T aq D N A  polym erase  (Promega). T he cy­
c ling  cond itions w ere 5 m in  a t 95°C, 27 cycles of 30 sec a t 
95°C /20 sec a t 64°C /60 sec a t 72°C, follow ed by 7 m in  a t 72°C. 
T he w ild-type, P3Fm, or P3Fa alleles resu lted  in  196-bp, 250-bp, 
or 575-bp bands, respectively.
For genotyping F khr m ouse lines, the  5' and 3 ' p rim ers 
w ere c k l4 2 , 5 '-C C T TC A G A G C T G C C A G G T G A A T A T G -3 ' 
and c k l4 3 , 5 '-T G T A G A G A G TA T G C C G TC C A G A G TG G -3 
ck30, 5 '-G T G T A C A A A C C A G C T G A G C A C -3 '; respectively. 
R eaction  cond itions w ere as described above except th a t 0.4 pM  
each p rim er w as used. C ycling  cond itions w ere 5 m in  a t 95°C, 
32 cycles of 30 sec a t 95°C /20 sec a t 64°C /60 sec a t 72°C, fo l­
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low ed by 7 m in  a t 72°C. T he w ild-type, F2-3p, or F2-3m  alleles 
resu lted  in  290-bp, 350-bp, or 661-bp bands, respectively.
For genotyping M yf6 -C re  m ouse  lines, th e  5 ' and 3 ' p rim ers 
w ere ck219, 5 '-C T T C A G C G C C T T T C T T C C A T C G -3 '; ba86, 
5 '-G G A TA G T G A A A C A G G G C A A -3 '; and ba88, 5 '-G A A C T T  
C G T T TG C A A C T G A C -3 '; ba97, 5 '-G A TC TG G A C G A A G A G  
C A TC A -3'; respectively . R eaction  cond itions w ere as described 
above except th a t 0.8 pM  each prim er w as used. C ycling  con­
d itio n s w ere th e  sam e as for Pax3:Fkhr. T he w ild-type, TCNm, 
and IC N p alleles resu lted  in  398-bp, 300-bp, or 550-bp bands, 
respectively.
Testing  M yf6  driver expression
W hole-m ount de tection  of th e  tissue-specific  CRE expression 
for th e  M yf6 -C re  m ouse  line  w as perform ed by crossing th a t 
line  to  R O SA 26  LacZ reporter m ice  (Sorriano 1999). Embryos 
w ere harvested  at E15.5 and processed as previously  described 
(A renkiel et al. 2003).
D etec tio n  o f  Pax3:Fkhr rearrangem ents in  various tissues
G enotyp ing  as described above w as perform ed on various tis ­
sues from  6-week-old m ice  w ith  th e  genotype Pax3p3tla/H' 1 
M y f6 rCNm/w 1 to  de te rm in e  th e  spec trum  of M yf6~C re-driven 
recom bina tion  for th e  Pax3:Fkhr knock-in  allele. For each or­
gan, 200 m g of tissue  w as diced and digested overnight in  330 
pg/m L  proteinase-K  in  100 m M  N aC l, 20 m M  T ris-C l (pH 7.6), 
10 m M  EDTA, and 0.5%  SDS. T he follow ing day, sam ples w ere 
ex tracted  w ith  phenol, ex tracted  w ith  chloroform , and precip i­
ta ted  w ith  2.5 vo lum es of e thanol. Sam ples w ere resuspended in  
TE, and 50 ng w as used  for th e  Pax3:Fkhr PCR genotyping re­
action  described above.
D etec tio n  o f  Pax3:Fkhr transcrip ts a n d  eYFP m a rker gene
For epifluorescence m icroscopy of ske le ta l m usc le  for 
Pax3:Fkhr m ice, 6-w eek-old an im als w ere killed  by C O , as­
phyx iation  and perfused w ith  PBS. T he vastus la te ra lis  m uscle  
w as dissected and fixed in  4%  paraform aldehyde in  PBS for 3 h  
a t 4°C. T h e  tissu e  w as w ashed for 10 m in  in  cold PBS four tim es, 
th en  tran s itio n ed  from  10% to  20% -30%  sucrose in  PBS at 
60-m in in tervals. T he tissu e  w as em bedded in  O C T  com pound 
(Sakura F inetek  U.S.A., Inc.) and snap-frozen on dry ice. Ten- 
m ic ron-th ick  cross-sections w ere subsequen tly  w ashed in  0.5%  
T rito n  X-100 in  PBS and coverslipped using  F luorM ount-G  
m o u n tin g  m edia  (Southern Biotech). Slides w ere v isualized  w ith  
a Z eiss A xiovert 200M  epifluorescence m icroscope using  a yfp 
filter.
H isto logy  a n d  im m u n o h is to c h e m is try  o f tu m ors
H istology w as perform ed as previously  described (Boulet and 
C apecchi 2004). Im m u n o h isto ch em istry  for m yogenin, sm oo th  
m uscle  actin , m uscle-specific  actin , C yclin  D l ,  C-M yc, and Bcl- 
XL w as perform ed by ARUP Laboratories a t th e  U n iv ersity  of 
U tah  on 3 .5 -pm  sections. A rabb it an ti-m ouse  FA1V secondary 
an tibody  (Dako Corp.) w as used to  avoid cross-reactiv ity  w ith  
nonspecific  m ouse tissu e  antigens. For Pax7, M yoD, and m yo­
genin  im m u n o h isto ch em is try  on frozen ske le ta l m usc le  (pre­
pared as described in  th e  p revious paragraph), s ta in ing  w as per­
form ed using  th e  M .O.M . T m m unodection Kit S ta in ing  Proce­
dure (Vector Laboratories) follow ing th e  m anu fac tu re r 's  
in stru c tio n s, w ith o u t an tigen  unm ask ing . T he Pax7 m o n o ­
clonal p rim ary  an tibody  (Pax7; D evelopm ental H ybridom a 
S tudies Bank, Iowa C ity , IA) w as used  a t a con cen tra tio n  of 1:10.
T he M yoD polyclonal p rim ary  an tibody  (PRB-106C; C ovance 
Corp.) w as used  a t a co n cen tra tio n  of 1:3000. T he m yogenin  
m onoclonal p rim ary  an tibody  (M3559; DAKO Corp.) w as used  
at a co n cen tra tio n  of 1:50. Slides w ere coverslipped w ith  Fluo- 
rom ount-G  (Southern B iotechnology A ssociates) or DAPI 
m o u n tin g  m ed iu m  (Vector Laboratories) and v isualized  by  s tan ­
dard ligh t m icroscopy. Im m u n o h isto ch em istry  using  rabbit 
polyclonal anti-Pax3 (Li et al. 1999) (a k ind  gift from  f. Epstein, 
U n iversity  of Pennsylvania, Philadelphia, PA), and rabb it poly­
clonal an ti-cM et (Jeffers et al. 1997) (a k ind  gift from  G. Vande- 
W oude, Van A ndel Research In s titu te , G rand Rapids, MI) were 
perform ed as previously  described.
C o m p u ted  tom ography scanning
C om puted  tom ography of sacrificed m ice  w as perform ed at 
93 p m 3 voxel reso lu tion  using  an eXplore Locus Sm all A nim al 
M icroC T  Scanner (GE H ealthcare). Im ages w ere reconstruc ted  
and v isualized  w ith  th e  m an u fac tu re r 's  M icroV iew  freeware.
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